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Interneurons, key regulators of hippocampal neuronal network excitability and
synchronization, are lost in advanced stages of Alzheimer’s disease (AD). Given
that network changes occur at early (presymptomatic) stages, we explored whether
alterations of interneurons also occur before amyloid-beta (Aβ) accumulation. Numbers
of neuropeptide Y (NPY) and parvalbumin (PV) immunoreactive (IR) cells were decreased
in the hippocampus of 1 month-old TgCRND8 mouse AD model in a sub-regionally
specific manner. The most prominent change observed was a decrease in the number
of PV-IR cells that selectively affected CA1/2 and subiculum, with the pyramidal layer
(PY) of CA1/2 accounting almost entirely for the reduction in number of hippocampal
PV-IR cells. As PV neurons were decreased selectively in CA1/2 and subiculum, and
given that they are critically involved in the control of hippocampal theta oscillations, we
then assessed intrinsic theta oscillations in these regions after a 4-aminopyridine (4AP)
challenge. This revealed increased theta power and population bursts in TgCRND8 mice
compared to non-transgenic (nTg) controls, suggesting a hyperexcitability network
state. Taken together, our results identify for the first time AD-related alterations
in hippocampal interneuron function as early as at 1 month of age. These early
functional alterations occurring before amyloid deposition may contribute to cognitive
dysfunction in AD.
Keywords: Alzheimer’s disease, neuropeptide Y, parvalbumin, hippocampal sub-regions, pre-plaque
Abbreviations: Aβ, Amyloid beta; AICD, Amyloid precursor protein intracellular domain; βCTF, C-terminal fragment beta;
AD, Alzheimer’s disease; CA, Cornu ammonis; DG, Dentate gyrus; GABA, γ-aminobutyric acid; GR, Granule cell layer;
MO, Molecular layer; NPY, Neuropeptide Y; PO, Polymorphic layer; PV, Parvalbumin; PY, Pyramidal layer; SO, Stratum
oriens; SR, Stratum radiatum.
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INTRODUCTION
Alzheimer’s disease (AD) is an age-related neurodegenerative
disorder characterized by progressive loss of cognitive and
executive functions. AD develops over decades, and although
overt stages are commonly studied, little is known about the
mechanisms occurring in the earliest stages (Prince et al.,
2014). Understanding these upstream mechanisms is crucial for
identifying early diagnostic biomarkers, as well as therapeutic
targets that could help modify disease progression more
efficiently.
The main histological hallmarks of AD are deposition of
amyloid beta (Aβ) peptides into extracellular amyloid plaques
and intracellular accumulation of hyperphosphorylated tau
protein (neurofibrillary tangles) (Hardy and Selkoe, 2002; Hardy,
2006). The prevailing theory regarding the cause of AD is the
amyloid cascade hypothesis, which posits that overproduction
of Aβ from amyloid precursor protein (APP) initiates a
series of events, including synaptic dysfunction, microglial and
astrocytic activation and hyperphosphorylation of tau, which
culminates in widespread neuronal death and neurodegeneration
(Hardy and Selkoe, 2002). In addition to the production
of Aβ, processing of APP along the amyloidogenic pathway
liberates beta C-terminal fragment (βCTF), the rate-limiting
precursor to Aβ (Chow et al., 2010). βCTF is also known
to have neurotoxic properties independent of the Aβ region
(Lee et al., 2000) and was associated with cortical atrophy
when cells expressing βCTF were transplanted in the brains
of newborn mice (Neve et al., 1992). Furthermore, transgenic
mice overexpressing βCTF also display extensive hippocampal
neuronal degeneration (Kammesheidt et al., 1992; Oster-Granite
et al., 1996), suggesting that Aβ may not be solely responsible
for AD pathology. Because βCTF accumulates prior to Aβ
(Cavanagh et al., 2013) and because its deleterious effects
such as neurodegeneration (Kammesheidt et al., 1992) and
synaptic abnormalities (Oster-Granite et al., 1996) resemble
those associated with Aβ, AD-related pathological alterations
may arise even earlier (i.e., before Aβ accumulation) than initially
thought.
It has been recently proposed that neurodegeneration
may stem from neuronal hyperexcitability. The regulatory
mechanisms controlling the excitability state of hippocampal
neuronal networks and preventing a transition towards a
state of excitability (i.e., a network hyperexcitability state)
have been examined in the hippocampus, yet the underlying
molecular and biochemical mechanisms remain unknown. This
functional regulation operates under physiological conditions
but is lost under pathological conditions (Niedringhaus et al.,
2015). Hyperexcitability, as manifested by epileptiform activity,
is observed at the earliest stages of AD in both humans and
mice (Palop et al., 2007; Gleichmann et al., 2011). Based
on this evidence, it has been hypothesized that neuronal
death is a consequence, rather than cause, of epileptic
seizures (Palop et al., 2007). Further, the Aβ-mediated increase
in hippocampal network excitability is associated with a
widespread increase in excitatory activity, with subsequent
negative impact on learning and memory (Palop et al., 2007;
Palop and Mucke, 2009). A similar increase in excitability
was detected after in vivo treatment of 1.5–2 month-old
TgCRND8 mice with pentylenetetrazole, a drug that inhibits
type-A γ-aminobutyric acid (GABA) receptors (Del Vecchio
et al., 2004). This may be due to the AD-related decrease
in parvalbumin (PV) neuron activation, which leads to
hyperexcitability (Verret et al., 2012). More recently, using the
same AD model, we have reported that subtle alterations in
synchronization of intrinsic hippocampal gamma and theta
oscillations are detected as early as 1 month of age in
TgCRND8mice (Goutagny et al., 2013). Given that hippocampal
network activity is coordinated by GABAergic neurons (Cobb
et al., 1995; Lawrence and McBain, 2003; Mann and Paulsen,
2007; Amilhon et al., 2015), GABAergic neuronal dysfunction
may lead to network over-excitation, and thus underlie an
increased susceptibility to seizures. Similarly, soluble Aβ can
disrupt excitatory-inhibitory balance, a specific AD-linked
(apoE4) genotype has been associated with impairment of
GABAergic interneurons, and GABAergic activation-induced
hyperpolarization prevents Aβ-related toxicity (Huang and
Mucke, 2012; Paula-Lima et al., 2013; Nava-Mesa et al., 2014).
However, the dysfunction of GABAergic interneurons in the
earliest AD-associated state of hippocampal excitability and
network synchronization has not been assessed.
Here, we investigated putative GABAergic interneuronal
impairment in 1 month-old TgCRND8 mice. Aβ pathology
progresses during the course of aging, and 6 month-old
TgCRND8 mice have high levels of Aβ and severe plaque load in
many brain regions, including the hippocampus (Chishti et al.,
2001). Although Aβ plaques are undetectable before 3 months
of age (Chishti et al., 2001), βCTF, the first cleavage product
of APP is expressed already at 1 month (Cavanagh et al.,
2013; Goutagny et al., 2013). Impaired performance in cognitive
tasks is first detectable at 2 months of age, but only when
more sensitive tests such as object recognition tasks are used,
as 2 month-old TgCRND8 mice are unimpaired on a Morris
water maze task (Francis et al., 2012). We chose to examine
TgCRND8 mice at 1 month of age because it corresponds to
the AD pathogenesis stage at which alterations in hippocampal
neuronal activity may be first detectable, as no difference
has been detected between 15 days-old TgCRND8 mice and
control littermates (Goutagny et al., 2013). We focused on
neuropeptide Y (NPY; Palop et al., 2011) and PV (Verret
et al., 2012) hippocampal interneurons, as both subtypes have
been shown to be particularly affected in AD. Moreover, NPY
and PV interneurons are critically involved in the control
of hippocampal excitability (Palop et al., 2007) and network




All experiments followed the policies and guidelines of the
Canadian Council on Animal Care and the animal care
regulations of McGill University. TgCRND8 mice bear Swedish
KM670/671NL and Indiana V717F mutations in the hAβAPP-
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encoding gene and overexpress human Aβ by 3–4 months. Male
TgCRND8 and non-transgenic (nTg) mice were maintained
on an outbred C3H/C57BL6 background and kept on a 12 h
light/dark cycle with food and water ad libitum.
βCTF ELISA
βCTF content was quantified from hippocampal homogenates
from Tg mice, as preliminary examination indicated that it is
undetectable in nTgmice (data not shown). This was expected, as
the antibody used in the enzyme-linked immunoabsorbent assay
(ELISA) kit (IBL International, Japan) is directed against the
human βCTF protein. Hippocampi from male TgCRND8 mice
(n = 8 mice) were dissected on ice, snap frozen and stored
at −80◦C until proteins were extracted. Hippocampus samples
were homogenized in radioimmunoprecipitation assay (RIPA)
buffer (100 µl per hippocampus) and left on ice for 30 min.
The samples were then centrifuged for 10 min at 1000 g at 4◦C.
The supernatants were collected and protein concentrations were
determined using a BCA assay kit (Pierce, Rockford, IL, USA).
The βCTF content was then assessed in triplicates using an ELISA
kit (IBL International, Japan) as per manufacturer’s instructions.
Briefly, samples were diluted in enzyme immunoassay (EIA)
buffer (1:100) and standards were prepared as directed. 100 µl of
each sample was loaded into the appropriate wells and incubated
overnight at 4◦C. The plate was then washed seven times
using diluted wash buffer. One hundred microliter of labeled
antibody solution was loaded into each well, and the plate was
incubated for 1 h at 4◦C. The plate was subsequently washed
nine times and 100 µl of chromogen was added to each well.
After 30 min of incubation in the dark at room temperature,
100 µl of stop solution was added to each well, and the plate
was analyzed using a plate reader at 450 nm against the reagent
blank.
Immunohistochemistry
Additional male mice (n = 5 mice per experimental group) were
anesthetized by pentobarbital and transcardially perfused (PBS
followed by 4% PFA). Brains were stored in fixative for 24 h
at 4◦C, then in a sucrose solution (30% in PBS) for 3 days at
4◦C, frozen using dimethylbutane and stored at −80◦C. Brains
were sliced coronally using a freezing microtome at 40 µm for
light microscopy, or using a vibrating microtome at 50 µm for
fluorescence microscopy, and free-floating sections were stored
in a cryopreservative solution (3:3:4 glycerol:ethylene glycol:PBS)
at −20◦C in preparation for IHC (IHC) staining. The serial
sectioning fraction for IHC was 1/8). Washes in PBS preceded all
steps except primary antibody addition. All steps were at room
temperature unless otherwise specified.
For immunofluorescence, sections were incubated for 5 min
with formic acid (90%). They were then incubated for 1 h
with PBS containing 1% normal goat serum, 0.25% Triton
X-100 and 0.45% gelatin. Sections were further incubated
overnight at 4◦C with either FCA3340 (Barelli et al., 1997)
to detect Aβ (Millipore 171608) or CT20 (Millipore 171610)
to detect βCTF (rabbit, 1:1000 dilution for both). Sections
were incubated for 2 h with secondary antibody (Alexa
555-conjugated goat anti-rabbit IgG; ThermoFisher A-21428,
1:2000). Sections were incubated with DAPI (1:10,000 dilution)
for 15 min at room temperature. Sections were then
mounted on glass slides with Fluoromount G. Fluorescence
was visualized using an epifluorescence (Axioplan2, Zeiss)
microscope.
For the study of neuronal populations, sections were
incubated in PBS with 0.2% Triton X-100 for 1.5 h, followed
by 3% H2O2 prepared in PBS for 10 min. The sections
were blocked with 2% normal serum in PBS + 0.2% Triton
X-100 for 1 h. Primary antibodies (NeuN: mouse, 1:200,
Millipore MAB377; NPY: rabbit, 1:2000, Abcam ab10980; PV:
rabbit, 1:5000, Abcam ab11427) were applied overnight at
4◦C, followed by biotinylated secondary antibodies (Vector
BA-1000, 1:200; BA-2001, 1:500) for 1 h. The immunolabeled
product was visualized using the avidin-biotin complex method
(Vectastain elite ABC Kit, Vector Laboratories; 30 min),
followed by DAB (for NeuN) or SG (for NPY and PV)
chromogen development (Vector Laboratories). Stained sections
were mounted on slides, dried overnight, dehydrated in ethanol,
cleared in xylene and coverslipped. Parallel sections from
the same animals were used across immunohistochemical
experiments.
Cell Quantifications
Immunoreactive (IR) cell somata were counted in each
hippocampal region and sub-region (from Bregma −1.06 mm
to Bregma −3.88 mm; Franklin and Paxinos, 2007), on a Nikon
Eclipse E600 (Kanagawa, Japan)microscope with a 20X objective,
by an experimenter blind to group identity. Anatomical regions
were determined as per Franklin and Paxinos (2007). CA1 and
CA2 were combined (CA1/2) due to the relatively amorphous
boundary separating these two regions. Intra-subject counts by
an additional experimenter (on a Leica DM 2500 microscope)
to confirm count/total accuracy correlated significantly
(p = 0.0062), with Pearson r and intraclass correlation values
>0.5. The serial section fraction was 1/8. Cell quantifications
are shown as numbers of cells per section to correct for
number of sections and for consistency between experiments.
Pairwise comparisons between nTg and TgCRND8 animals
in hippocampal regions and sub-regions were performed
using unpaired t-tests, with Welch’s correction applied when
required.
For GABAergic markers, we were able to count each labeled
cell in order to quantify. However, given the large number
of NeuN-labeled cells, it was necessary to use stereological
estimates to quantify this marker, as in previous studies
(Pham et al., 2003). Although this method relies on estimates
as opposed to absolute cell counts, and is not appropriate
for quantification of all hippocampal cell types (Noori and
Fornal, 2011), it is an optimal quantification method for
this larger cellular population. NeuN-IR quantifications were
performed by an experimenter blind to group identity on
an Olympus BX51 microscope with a motorized stage, using
StereoInvestigator software (MBF Bioscience). The stereological
parameters (optimized for the NeuN-IR population) were:
sampling grid area 28440 µm2, counting frame 25 µm× 25 µm,
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dissector height 10 µm, guard zone 1 µm. Volume was
assessed using a Cavalieri estimator (20 µm grid spacing)
corrected for overprojection. Average coeffecients of error
for Cavalieri probes were 0.025 for CA1/2 and CA3 and
0.033 for dentate gyrus (DG), and for optical fractionator
(Gundersson m = 1) were 0.051 for CA1/2, 0.060 for CA3 and
0.054 for DG.
Electrophysiology
Tg and nTg mice (aged 30–35 days; n = 6/group) were
decapitated, and the brain was rapidly removed and placed in
ice-cold high sucrose artificial CSF (ACSF) solution (in mM:
252 sucrose, 3 KCl, 2 MgSO4 24 NaHCO3, 1.25 NaH2PO4,
1.2 CaCl2 and 10 glucose) and bubbled with carbogen
(95% O2 and 5% CO2). The cerebellum and frontal cortex
were removed with a razor blade, and the hemispheres were
separated and allowed to recover for 2–3 min in the oxygenated
sucrose solution. Complete septo-hippocampal isolate was
then removed from the remaining hemisection as described
previously (Goutagny et al., 2009). After dissection, the
complete septo-hippocampal preparation was left at room
temperature in ACSF bubbled with carbogen for 60 min.
For recording, the preparation was transferred quickly to
a custom-made submerged recording chamber. Recordings
were performed at 30–32◦C after an additional 30 min period
in the chamber. The preparation was continuously perfused
with ACSF (25 ml/min, in mM: 126 NaCl, 24 NaHCO3,
10 glucose, 4.5 KCl, 2 MgSO4, 1.25 NaH2PO4 and 2 CaCl2,
pH 7.4, with 95% O2/5% CO2) via a gravity-fed perfusion
system and maintained at 30–32◦C. Local field potentials
were recorded using glass micropipettes (2–6 MΩ) filled
with ACSF. Signals were recorded through a differential
AC amplifier (A-M Systems), filtered online (0.1–500 Hz),
and sampled at 5 KHz. All drugs came from aliquots of
stock solutions (stored at −80◦C) and were added to the
perfusing artificial ACSF at the concentrations indicated.
Base line recording lasted for 20 min followed by 100 s
of pharmacological stimulation (4AP at 150 µM) and
20 min recovery after stimulation. Changes in theta power
were measured in mV2/Hz. Pairwise comparisons were
performed with t-tests. For all experiments, a p value of
≤0.05 considered statistically significant. Bar graphs show
experimental mean, with error bars indicating standard error of
the mean.
RESULTS
Immunohistochemical Assessment of Aβ
and βCTF in the Hippocampus of 1
Month-Old TgCRND8 Mice
Immunohistochemical staining for three neuronal markers
(NeuN, NPY and PV) revealed distributional patterns in
CA1/2, CA3, DG and subiculum (Figure 1A) that have been
FIGURE 1 | Expression of neuronal markers and amyloid-beta precursor protein (APP) cleavage products in the hippocampus of 1 month-old
TgCRND8 mice. (A) Micrographs of immunohistochemical labeling of hippocampal neurons for NeuN, neuropeptide Y (NPY) and parvalbumin (PV) in CA1 and 2,
CA3, dentate gyrus (DG) and subiculum (SUB) hippocampal regions. Scale bar = 50 µm. (B) Amyloid-beta (Aβ) and C-terminal fragment/Amyloid precursor protein
intracellular domain (CTF/AICD) expression as assessed by FCA3340 and CT20 antibodies, respectively. Anatomically matched hippocampal sections of CA1/2
sub-region of 11 month-old TgCRND8 mice were used as a positive control. Scale bar = 100 µm.
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described previously (Albuquerque et al., 2015). Assessment of
Aβ and amyloid-plaques using the FCA3340 antibody, which
specifically recognizes human Aβ but not APP (Barelli et al.,
1997), indicated no immunolabeling in hippocampus sections
obtained from 1 month-old TgCRND8 mice, in contrast to
the abundance of plaques present in the hippocampus of
11 month-old TgCRND8 mice, used as a positive control
(Chishti et al., 2001; Figure 1B). However, the CT20 antibody
which recognizes both human and murine full length APP
and its C-terminal fragments (CTF) α, β and amyloid
precursor protein intracellular domain (AICD) but not Aβ,
revealed IR cells, notably in the pyramidal cell layer of
the CA1/CA2 region (Figure 1B). CT20-IR cells displayed
punctate cytoplasmic labeling (Figure 1B). Combined, the
labeling data obtained with FCA3340 and CT20 indicated
that immunoreactivity likely arises from the presence of APP
and its first cleavage products (CTFs) in the absence of
Aβ. Since the observed putative CTF-IR could arise from
different fragments (αCTF, βCTF or AICD) generated along
either the amyloidogenic and non-amyloidogenic pathways,
we performed a selective βCTF ELISA to assess whether the
CT20-IR could be due specifically to the βCTF. The presence
of βCTF was confirmed and quantified (1.47 pg βCTF/mg
protein ± 0.22, range 0.80–2.43 pg βCTF/mg protein) by
ELISA in the hippocampal tissue of TgCRND8 mice aged
1 month.
Global Phenotypic Analysis of the
Composition of Selected Hippocampal
Neuronal Populations
Phenotypic analysis along the rostro-caudal axis (−0.94 to
−2.86 mm from Bregma) using the neuronal marker NeuN
indicated that both total number (Figure 2A) and density
(Figure 2C) of neurons were similar between genotypes
in all studied regions of the hippocampus (CA1/2, CA3
and DG). Interestingly, structural volume was significantly
decreased for TgCRND8 mice in CA3 (p = 0.041) and
DG (p = 0.017) but not CA1/2, as compared to controls
(Figure 2B).
However, when assessing specifically NPY (Figure 3A;
p = 0.016) or PV (Figure 3B; p = 0.016) subpopulations,
FIGURE 3 | Quantification of NPY- (A), and PV-immunoreactive (IR; B) cells
in the overall hippocampus for nTg and Tg animals. ∗p < 0.05.
a significant decrease in numbers of IR-cells was found
in TgCRND8 mice compared to age-matched nTg
littermates.
Regional and Sub-Regional Distribution of
NPY- and PV-Expressing Neurons
A more detailed analysis indicated that the overall number of
NPY neurons is decreased in hippocampal sub-regions CA1/2
(p = 0.021) and DG (p = 0.0033), but not CA3 or subiculum
(Figures 4A–D) of TgCRND8mice as compared to controls. The
most affected sub-regions in CA1/2 were the stratum pyramidale
(p = 0.021) and oriens (p = 0.026) layers (Figure 4E). No
significant difference was seen between genotypes in the layers of
CA3 (Figure 4F). By contrast, in the DG, the polymorphic layer
(PO; p = 0.0031) and granule cell layer (GR; p = 0.0051) showed
alterations in TgCRND8mice, whereas the molecular layer (MO)
was unaffected (Figure 4G).
An analogous analysis of PV-expressing neuronal
sub-populations showed a significant decrease in the number of
these neurons in CA1/2 (Figure 5A; p = 0.017) and subiculum
(Figure 5D; p = 0.030) whereas CA3 (Figure 5B) and DG
(Figure 5C) were not significantly affected. Among the layers
analyzed in these sub-regions (Figures 5E–G), the number of
PV-expressing neurons in TgCRND8 mice was significantly
decreased only in the pyramidal cell layer of the CA1/2 region
(Figure 5E; p = 0.0004).
A recent study reported that PV-expressing neurons at
the interface between CA1/2 and subiculum are the primary
regulators of hippocampal neuronal network oscillations at
theta frequencies (Amilhon et al., 2015). Therefore, we decided
FIGURE 2 | Quantification of NeuN-immunoreactive neurons in the hippocampus of 1 month-old TgCRND8 mice. Number of neurons (A), average layer
volume (B) and neuronal density (C) in the studied hippocampal sub-regions (CA1/2, CA3 and DG) were examined. nTg, non-transgenic; Tg, transgenic. ∗p < 0.05.
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FIGURE 4 | Quantification of NPY-IR cells in CA1/2 (A), CA3 (B), dentate gyrus (DG; C) and subiculum (D), as well as sub-regions within CA1/2 (E), CA3 (F) and
DG (G). nTg, non-transgenic; PO, polymorphic layer; SO, stratum oriens; SR, stratum radiatum; Tg, transgenic. ∗p < 0.05; ∗∗p < 0.01.
FIGURE 5 | Quantification of PV-IR cells in CA1/2 (A), CA3 (B), dentate gyrus (DG; C) and subiculum (D), as well as sub-regions within CA1/2 (E), CA3 (F) and
DG (G). nTg, non-transgenic; PO, polymorphic layer; SO, stratum oriens; SR, stratum radiatum; Tg, transgenic. ∗p < 0.05; ∗∗∗p < 0.001.
to focus further on the PV-expressing sub-population of
interneurons.
Assessment of Amyloid in PV-Expressing
Neurons
To explore the mechanisms of the observed decrease in
the number of PV-expressing interneurons in 1 month-old
TgCRND8 mice, we used a double-labeling approach to
determine whether, in the absence of Aβ (Figure 1B),
PV-expressing neurons may co-express βCTF. Using anti-PV
and FCA3340 antibodies, we first confirmed the absence of Aβ
in the PV-IR neurons located in the pyramidal layer (PY) of
CA1 in 1 month-old TgCRND8 mice (Figure 6A). By contrast,
in the anatomically matched hippocampal region from 11
month-old TgCRND8mice, which was used as a positive control,
cytoplasmic Aβ labeling was revealed in pyramidal neurons.
As our ELISA data demonstrated βCTF expression in the
hippocampus in 1 month-old TgCRND8 mice, we next asked
whether PV-expressing neurons may also express βCTF. Our
double-labeling approach indicated that CTF-IR (as revealed
by the CT20 antibody) does not co-localize with PV-IR
(Figure 6B). Interestingly, in 1 month-old TgCRND8 mice,
APP and CTFs were apparently localized in the upper portion
of the pyramidal cell layer where PV-IR neurons were
virtually never detected (Figure 6B). Indeed, PV-expressing
neurons were localized in the lower portion of the PY
(Figure 6B).
Functional Assessment of Hippocampal
Network Excitability
Transgenic mouse models of AD at 5 months of age are
characterized by high levels of Aβ peptides potentially leading
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FIGURE 6 | Analysis of the co-expression of APP cleavage products
and PV-IR in CA1 hippocampal neurons of 1 month-old
TgCRND8 mice. (A) Micrographs of immunohistochemical labeling of
hippocampal neurons for PV and Aβ; anatomically matched sections from
11 month-old mice were used as a positive control. Note that in contrast to
the absence of Aβ-IR in 1 month-old TgCRND8 mice, intracytoplasmic Aβ is
clearly detectable in the pyramidal layer (PY) of the CA1 region of
11 month-old TgCRND8 mice. (B) Analysis of Aβ/CTF expression in
CA1 hippocampal PV neurons in 1 month-old TgCRND8 mice. As Aβ was
undetectable when assessed with the selective FCA3340 Aβ antibody, and
enzyme-linked immunoabsorbent assay (ELISA) detected a substantial
amount of βCTF, this immunoreactivity reveals likely the expression of βCTF.
However, no PV-IR neurons co-expressing βCTF were observed. Scale
bar = 10 µm.
to network hyperexcitability (Palop et al., 2007). However, our
recent data examining Tg mice at 1 month of age has not
indicated the presence of Aβ peptide (Goutagny et al., 2013);
instead, we observed elevated βCTF and decreased numbers
of hippocampal PV-expressing neurons in the current study.
Aiming to assess whether these alterations could account
for network hyperexcitability (changes in theta amplitude,
theta frequency and burst (seizure) events), we utilized
4-aminopyridine (4AP) in a complete septo-hippocampal
preparation (Goutagny et al., 2009). The hyperexcitability
network state is achieved by blocking primarily Kv1 channels,
which consequently induces activity reflecting the firing of
GABA-releasing cells and is sustained by GABAA receptor
signaling (Avoli and de Curtis, 2011). Our hypothesis was
that 4AP would reveal a state of hyperexcitability in juvenile
TgCRND8 mice.
Treatment with 4AP did not elicit a visible change in
the amplitude of theta activity in nTg mice (Figures 7A,B,
red square). Conversely, in Tg mice 4AP treatment affected
amplitude of hippocampal theta activity (Figure 7D, red
square). Magnification of raw activity traces confirmed an
increase in theta amplitude of Tg mice during 4AP treatment
(Figure 7E). As shown in the spectrogram analysis, theta
oscillations frequency remains stable (4.10 ± 1.68 Hz) in nTg
mice when treated with 4AP (Figure 7C, red square). In
contrast, although not statistically significant (p = 0.29), Tg
mice showed changes in frequency during 4AP stimulation
(Figure 7F, red square). Statistical analysis further confirmed
our findings, as no significant changes were detected in
frequency either during (p = 0.29) or after 4AP stimulation
(p = 0.53; Figures 7G,H). Concomitantly, statistical analysis
further confirmed the 7.5 ± 2.44-fold increase in theta power
during 4AP stimulation in Tg mice (Figure 7I, p = 0.02). The
increase was also significant after 4AP stimulation (Figure 7I,
5.03 ± 1.29 p = 0.01). The changes in theta peak power were
also significant when Tg mice were compared to nTg during
4AP (Figure 7J, p = 0.038) and after stimulation (Figure 7J,
p = 0.023).
At this point, the data suggested that the network state in
TgCRND8 mice is closer to a hyperexcitability-like state when
compared to controls. To further explore the excitability network
state, we analyzed the number of burst events present in the
nTg (Figure 7K) and Tg mice (Figure 7L). Our results showed
an elevated number of burst events in Tg mice when treated
with 4AP (Figure 7L), further supporting a hyperexcitability-like
network state. In contrast, control mice showed a more stable
network state (Figure 7K). Further statistical analysis confirmed
a two-fold increase (2.4 ± 0.19-fold, p = 0.012) in relative burst
events in Tg mice when compared to nTg mice (Figures 7M,N).
DISCUSSION
Alterations in hippocampal neuronal excitability (Del Vecchio
et al., 2004; Palop and Mucke, 2010; Verret et al., 2012) and
synchronization of hippocampal oscillatory activity (Goutagny
et al., 2013) occur at the first stages of AD pathogenesis,
via as yet poorly understood mechanisms. Here, we found
that a significant decrease in the number of hippocampal
NPY- and PV-IR cells in 1 month-old TgCRND8 mice
coincides with the early impairment of neuronal network
activity. This decrease was distributed between hippocampal
regions CA1/2 and DG for NPY. The decreased number of
PV-IR cells selectively affected CA1/2 and subiculum, with
the PY of CA1/2 accounting almost entirely for the reduction
in number of hippocampal PV-IR cells. This decrease in
NPY-and PV-IR cells was observed in the absence of change
in total numbers of hippocampal neurons (NeuN-IR) in the
studied principal layers, suggesting that decreases in numbers
of NPY- and PV-IR cells are not the result of neuronal
death occurring in the studied hippocampal layers but may be
related to loss of expression of particular GABAergic markers
(see ‘‘Discussion’’ Section in Uchida et al., 2014), although
contribution by specific GABAergic population cell death cannot
be conclusively ruled out by the current data. We observed
decreased volume of CA3 and DG, potentially representing
changes in neuropil. Moreover, the change in GABAergic cells
was observed at a stage wherein βCTF, the first cleavage
product of APP and direct precursor of Aβ, was abundant.
Our work (Goutagny et al., 2013; present study) is the first
reporting on AD-related hippocampal dysfunction at such an
early stage of pathogenesis. However, cortical hyperexcitability
was recently correlated with βCTF (Xu et al., 2015) in 2–4
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FIGURE 7 | Electrophysiological monitoring of CA1/subiculum neurons in response to 4AP challenge. Raw traces of theta oscillations recorded in
CA1/subiculum area using septo-hippocampal preparations from non-transgenic (nTg; A) and transgenic (Tg) mice (D). In nTg mice, 150 µM-4AP treatments did not
change theta amplitude (A, red square). Conversely, in TgCRND8 mice 4AP treatments altered theta amplitude (D, red square). Magnification of raw theta activity
before, during and after 4AP treatment in nTg (B) and TgCRND8 mice (E). Power spectrum analysis of theta power and frequency in nTg (C) and
(Continued)
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FIGURE 7 | (Continued)
TgCRND8 mice (F). Theta frequency did not show statistically significant
changes in TgCRND8 4AP-treated animals (G,H, different colors correspond
to individual TgCRND8 samples). TgCRND8 mice reveal theta power increase
during and after 4AP treatment (I,J, red circles denote averages, black circles
denote individual TgCRND8 traces). Under 4AP challenge, elevated number of
burst events was observed in TgCRND8 mice (L) compared to nTg (K).
Relative change of burst events is higher in TgCRND8 mice (N, representative
trace of burst events after 4AP in L) compared to nTg mice (M, representative
trace of burst events after 4AP in K). Burst events were significantly increased
for TgCRND8 mice (see inset in N). ∗p < 0.05.
month-old Tg2576 mice prior to plaque formation (Duffy et al.,
2015), thus further pointing to dysregulation of excitability
as a general feature of initial AD stages. As a corollary,
currently available AD mouse models should be studied at much
earlier ages than have been previously examined, specifically
in the context of putative early impairments of GABAergic
interneurons.
Electrophysiological monitoring of theta oscillations in the
distal CA1/subiculum of TgCRND8 mice revealed increased
power, without change in frequency of theta oscillation
in comparison to nTg littermates. These findings suggest
altered control of hippocampal network excitability state as
a potential mechanism of network dysfunction seen during
early stages of AD development at the same age (1 month-
old) and the same strain (TgCRND8) of AD mouse model
(Goutagny et al., 2013). Furthermore, although 4AP triggered
burst activity in neuronal populations of both genotypes, the
relative change of burst events was significantly higher in
TgCRND8 mice than in controls, suggesting an AD-associated
hyperexcitability. Therefore, treatment with 4AP appeared to
induce a prodromal network hyperexcitability-like state in the
studied 1 month-old TgCRND8 mice, as previously seen in older
mice of the same strain (Jolas et al., 2002; Del Vecchio et al.,
2004).
Given the recently demonstrated pivotal role of
PV-expressing GABAergic neurons in the generation of
theta oscillations in the isolated hippocampus (Amilhon
et al., 2015), these data suggest that the loss of PV-expression
in GABAergic neurons may be causal to their functional
impairment. Thus, the decrease in number of functional PV
neurons in the absence of their death (as attested by the absence
of difference in the number of hippocampal NeuN-IR neurons
between genotypes) may contribute to the loss of inhibitory
tone and subsequent increased excitability of pyramidal cells.
As PV neurons are key for the synchronization of pyramidal
cells, this loss of PV expression can likely have a critical
impact on CA1 network activity. Furthermore, the observed
AD-related hyperexcitability may in turn be related to the
previously reported uncoupling of theta/gamma oscillations
(Goutagny et al., 2013). In addition to effects on excitability,
the loss of PV neurons may also influence hippocampal
plasticity. Indeed, in a recent study LTP was enhanced in
rat hippocampal slices after application of an α7–nicotinic
acetylcholine receptor agonist in part through an enhancement
of a GABAergic receptor subtype (Townsend et al., 2016).
The effect of phenotypic changes in GABAergic neurons on
synaptic plasticity should also be explored, especially given the
implication of PV cells in AD (Verret et al., 2012). Notably,
synaptic hyperexcitability in CA1, which has been reported
in 5 month-old TgCRND8 mice (Jolas et al., 2002), is present
much earlier, as is shown here at the age of 1 month, before
Aβ overproduction. At this time point βCTF is detectable,
and given that this protein has been previously associated
with impairments in synaptic function (Nalbantoglu et al.,
1997; Tamayev et al., 2012), the presence of βCTF raises
the possibility that this neurotoxic protein may be affecting
GABAergic subpopulations. In this light, decreased numbers
of NPY-IR neurons in the stratum oriens (SO) and pyramidale
of the CA1 region, combined with the significant loss of PV-IR
in the PY of CA1, would likely have major consequences in
terms of control of pyramidal cell excitability. Indeed, cells
in the SO project to distal dendrites of CA1 pyramidal cells
and provide dendritic inhibition (Maccaferri and Lacaille,
2003). It has to be stressed however that, because of the
very young (1 month) age at which we assessed the putative
changes in the hippocampus of TgCRND8 mice, the possibility
remains that the observed decreased numbers of the PV
neurons may be related to the incomplete maturation of
the GABAergic neurons, rather than to their AD-related
decrease. This possibility is nevertheless very unlikely, as our
previous study demonstrated that at the age of 2 weeks, there
is no difference in the hippocampal network activity between
TgCRND8 mice and their age-matched nTg controls (Goutagny
et al., 2013).
A previous phenotypic analysis of hippocampal GABAergic
neuronal populations at the overt stages of AD pointed to
selective loss in number or function of specific sub-types, notably
neurons expressing NPY (Ramos et al., 2006; Albuquerque et al.,
2015), and PV (Verret et al., 2012; Albuquerque et al., 2015).
As with the aforementioned CA1 synaptic hyperexcitability,
our results indicate that the change in the composition of
certain GABAergic sub-populations may occur much earlier
than previously believed. This is particularly striking for
NPY-expressing GABAergic neurons that, by the age of 1 month
(in the present study), have already decreased substantially in
number, similar to 6 month-old TgCRND8 mice (Albuquerque
et al., 2015) in all studied hippocampal regions. By contrast,
the alteration of PV-expressing neurons appears more complex
because the decreased expression of PV found in CA1 and
subiculum at 1 month of age is not detectable in 6 month-old
animals (Albuquerque et al., 2015). Additionally, in another AD
mouse model (APP/PS1), a significant loss of PV neurons was
shown in CA1/2 region of 10 month-old mice (Takahashi et al.,
2010). A putative loss of PV neurons in older TgCRND8 mice
cannot be completely excluded as these mice have not been
studied at ages older than 6 months (Albuquerque et al.,
2015).
Collectively, our data indicate that before the loss of
GABAergic neurons in AD mouse models (Krantic et al., 2012;
Albuquerque et al., 2015), GABAergic neurons undergo
substantial alterations that potentially increase seizure
susceptibility (Palop et al., 2007). These include changes in
neurochemical phenotype and composition of GABAergic
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subpopulations, compatible with the increased excitability
revealed here with 4AP. Similarly, the shift from hyperpolarizing
towards depolarizing actions (Lagostena et al., 2010) has been
proposed to aggravate increased excitability resulting from
loss of GABAergic neurons. Moreover, in the J20 line of
hAPPFAD mice, PV neurons displayed greater depolarization
of the resting membrane potential and reduced action
potential amplitude (Verret et al., 2012). However, other
alterations, such as increased numbers of NPY-expressing
cells and GABAergic sprouting in the DG, may counteract
the AD-related hyperexcitability (Palop et al., 2007) through
compensatory remodeling of GABAergic neuronal population
composition.
Finally, our data show that the decrease in PV-IR and NPY-IR
cells is present at 1 month, whereas the number of NeuN-IR
cells is unaltered, suggesting that phenotypic alterations of
GABAergic neurons occur without neuronal loss at this early AD
pathogenic stage. Functional changes manifesting as decreased
PV and NPY expression, and increased synaptic excitability
in CA1, all occur well before GABAergic cell death, which is
not detectable before 6 months in TgCRND8 (Krantic et al.,
2012; Albuquerque et al., 2015) and AβPPdE9 (Ramos et al.,
2006) mice. This represents additional evidence supporting
the hypothesis that hyperexcitability and increased seizure
susceptibility are the cause rather than the consequence of
AD-related neuronal death (Palop et al., 2007). Moreover, our
study suggests that at early stages of AD-related pathology,
GABAergic neurons downregulate at least some of their
neurochemical markers (PV, NPY) but remain present, as no
neuronal loss was detected by stereological quantification of
NeuN-IR cells. A similar phenomenon has been observed in
schizophrenia, both in animal models (Nullmeier et al., 2011)
and patients (Akbarian et al., 1995; Impagnatiello et al., 1998;
Guidotti et al., 2000; Hashimoto et al., 2003; Lewis et al.,
2005).
In conclusion, this study reveals early alterations in
hippocampal neuronal phenotypes that are associated with
a functional increase in oscillatory activity and precede Aβ
accumulation. These findings suggest that AD etiology may
involve hippocampal GABAergic alterations occurring before
appearance of symptoms and plaque formation.
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